Efficacy News and Research

RSS
Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Intact Vascular to present TOBA II pivotal clinical trial data at VIVA Conference

Intact Vascular to present TOBA II pivotal clinical trial data at VIVA Conference

The feds’ termination of a tiny contract inflames bitter fight over fetal tissue

The feds’ termination of a tiny contract inflames bitter fight over fetal tissue

Joint research team discovers potential new treatment for severe malaria

Joint research team discovers potential new treatment for severe malaria

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Immunotherapy effective for individuals with inherited form of skin cancer

Immunotherapy effective for individuals with inherited form of skin cancer

Scientists discover new molecular pathway that controls colorectal cancer development

Scientists discover new molecular pathway that controls colorectal cancer development

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Study shows adherence to annual lung cancer screening is not optimal

Study shows adherence to annual lung cancer screening is not optimal

FDA approves HEMLIBRA for treatment of hemophilia A

FDA approves HEMLIBRA for treatment of hemophilia A

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

New ReFRAME drug repurposing collection offers hope for treating major diseases

New ReFRAME drug repurposing collection offers hope for treating major diseases

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.